Akums is among the largest domestic market-focused Indian CDMOs on a revenue basis serving IPM, with a market share of 9.3% by value in FY23 in the total addressable Indian domestic CDMO market and 8.8% by volume in the total IPM market in FY23. In the Indian domestic CDMO market, the company had a market share of 29.4% by value in FY23, which increased from 26.7% in FY21. With creme-de-la-creme of dedicated pharmaceutical personnel and standardized practices, Akums has been successful in attaining national and international accreditations and building trust on Efficacy, Safety & Quality. The organization is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015, ISO 50001:2018, ISO 45001:2018, and ISO 22000:2018 certificates and various international accreditations, like; FDA Philippines, NMPB Sudan, NDA Uganda, Cambodia, Indonesia, Nigeria, Malawi amongst others